Shield Therapeutics plc (STX) — Free Cash Flow Generation Index
Latest as of June 2020:
1.00x
Shield Therapeutics plc (STX) has a Free Cash Flow Generation Index of 1.00x as of June 2020. Free cash flow of GBX2.39 Million represents 1% of operating cash flow (GBX2.40 Million). Explore STX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
GBX2.39 Million
GBX
Operating Cash Flow
GBX2.40 Million
GBX
Capital Expenditures
GBX2.00K
GBX
Annual Free Cash Flow Generation for Shield Therapeutics plc (None–None)
Year-by-year Free Cash Flow Generation Index for Shield Therapeutics plc. Check STX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).